BenefitsPRO: Employee Benefits News, Trends & Sales Tips

Challenges to noncompete ban already hitting courts

By Maria Dinzeo

"If you take this to its natural extension, the FTC is invalidating hundreds and hundreds of years of a common law, of statutes being implemented on this topic," Jason Tremblay, a partner with Saul Ewing, said.

Read Story

News

Drugmakers, hospitals spar over new 340B drug discount 'dispute resolution' process

News

Eli Lilly's $35 insulin cap could unravel, as $13.5M class action settlement falls apart

Recommended Just For You

News Stories

April 26, 2024

Elevance Health partners with private equity to boost primary care for 1M consumers

Elevance Health, which is the parent company of Blue Cross and Blue Shield Health insurance plans in 14 states, has partnered with a private equity firm, forging a new offering that will take a whole health approach to primary care.

Read

April 26, 2024

30% of younger generations worry about finances, study finds

Almost 7 in 10 young adults agree their employer should provide services that address financial stress.

Read

April 25, 2024

As Medicare Part D grows, so does need for fraud audits

CMS is required to audit the financial records of at least one-third of Part D plan sponsors annually.

Read

April 25, 2024

Uneven playing field: Can you afford to be well where you live?

A doctor visit costs on average 3.1 times more in Juneau, Alaska, than in Laredo, Texas.

Read

April 25, 2024

Divided FTC finalizes rule to ban noncompete agreements

"First, in my mind, the plain text of the FTC Act clearly gives the agency the authority to promulgate rules addressing unfair methods of competition," FTC Chair Lina Khan said. Not everyone agrees.

Read

April 25, 2024

Big Pharma and pharmacy benefit managers sued for insulin price-fixing

The health fund for the International Union of Operating Engineers is suing Eli Lilly, Novo Nordisk and Sanofi, as well as CVS Health and other PBMs, for "drastically" increasing the price of life-saving meds for "illicit profits."

Read

April 25, 2024

Drug shortages at all-time high: Supplies are low for Amoxicillin, chemo meds, Ozempic

In the first quarter of 2024, 323 drugs were in short supply, up from the previous high of 320 in 2014, says the University of Utah Drug Information Service, as policymakers propose giving the FDA more power over Big Pharma.

Read

‹ ‹ PREV 270 271 272 ... 734 › NEXT ›

News

Top News Stories

Challenges to noncompete ban already hitting courts

Drugmakers, hospitals spar over new 340B drug discount 'dispute resolution' process

Eli Lilly's $35 insulin cap could unravel, as $13.5M class action settlement falls apart

Recommended Just For You

News Stories

Elevance Health partners with private equity to boost primary care for 1M consumers

30% of younger generations worry about finances, study finds

As Medicare Part D grows, so does need for fraud audits

Uneven playing field: Can you afford to be well where you live?

Divided FTC finalizes rule to ban noncompete agreements

Big Pharma and pharmacy benefit managers sued for insulin price-fixing

Drug shortages at all-time high: Supplies are low for Amoxicillin, chemo meds, Ozempic